DE4121001C1 - - Google Patents

Info

Publication number
DE4121001C1
DE4121001C1 DE19914121001 DE4121001A DE4121001C1 DE 4121001 C1 DE4121001 C1 DE 4121001C1 DE 19914121001 DE19914121001 DE 19914121001 DE 4121001 A DE4121001 A DE 4121001A DE 4121001 C1 DE4121001 C1 DE 4121001C1
Authority
DE
Germany
Prior art keywords
dideoxy
guanine
dideoxyguanosine
didehydro
dideoxyadenosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE19914121001
Other languages
German (de)
English (en)
Inventor
Eckert Dr. O-1115 Berlin De Matthes
Martin Von Dr. O-1185 Berlin De Janta-Lipinski
Renate Dr. O-2200 Greifswald De Mentel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAX-DELBRUECK-CENTRUM fur MOLEKULARE MEDIZIN BERLIN-BUCH O-1115 BERLIN DE
Original Assignee
MAX-DELBRUECK-CENTRUM fur MOLEKULARE MEDIZIN BERLIN-BUCH O-1115 BERLIN DE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAX-DELBRUECK-CENTRUM fur MOLEKULARE MEDIZIN BERLIN-BUCH O-1115 BERLIN DE filed Critical MAX-DELBRUECK-CENTRUM fur MOLEKULARE MEDIZIN BERLIN-BUCH O-1115 BERLIN DE
Priority to DE19914121001 priority Critical patent/DE4121001C1/de
Priority to PCT/DE1992/000515 priority patent/WO1993000099A2/de
Application granted granted Critical
Publication of DE4121001C1 publication Critical patent/DE4121001C1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE19914121001 1991-06-21 1991-06-21 Expired - Fee Related DE4121001C1 (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE19914121001 DE4121001C1 (zh) 1991-06-21 1991-06-21
PCT/DE1992/000515 WO1993000099A2 (de) 1991-06-21 1992-06-19 Verwendung von pyrimidin- und purinnucleosiden zur prophylaxe und/oder behandlung von durch adenoviren verursachten infektionen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19914121001 DE4121001C1 (zh) 1991-06-21 1991-06-21

Publications (1)

Publication Number Publication Date
DE4121001C1 true DE4121001C1 (zh) 1993-05-06

Family

ID=6434725

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19914121001 Expired - Fee Related DE4121001C1 (zh) 1991-06-21 1991-06-21

Country Status (2)

Country Link
DE (1) DE4121001C1 (zh)
WO (1) WO1993000099A2 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112512529B (zh) * 2018-07-27 2024-06-18 富士胶片株式会社 环戊烯嘌呤衍生物或其盐

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8719877D0 (en) * 1987-08-22 1987-09-30 Wellcome Found Antiviral compounds
GB8822546D0 (en) * 1988-09-26 1988-11-02 Wellcome Found Antiviral combinations

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J. Med. Chem. 30, 1987, 1270-1278 *
J. Med. Chem. 33, 1990, 17-21 *

Also Published As

Publication number Publication date
WO1993000099A3 (de) 1993-03-18
WO1993000099A2 (de) 1993-01-07

Similar Documents

Publication Publication Date Title
DE69933860T2 (de) 2'-fluoronukleoside
DE69636734T2 (de) Nucleoside mit anti-hepatitis b virus wirksamkeit
DE3689220T2 (de) Hemmung der In-vitro-Infektivität und des zytopathischen Effektes von HTLV-III/LAV durch 2'3'-Dideoxyinosin, 2'3'-Dideoxyguanosin oder 2'3'-Dideoxyadenosin.
DE69929060T2 (de) Beta-l-2'-deoxynukleoside für die behandlung von hepatitis b virus
DE60208794T2 (de) 4'-substituierte nukleoside zur behandlung von hepatitis-c-virus-vermittelten erkrankungen
CA1302263C (en) Therapeutic nucleosides
DE69318031T2 (de) Ematiomerenreine beta-d-dioxolane nucleoside mit selektiver antihepatitis b-virus wirkung
CA2637774C (en) Nucleosides with anti-hepatitis b virus activity
EP0254268B1 (de) Fluorierte Nucleoside, ihre Herstellung und ihre pharmazeutische Verwendung gegen AIDS
DE69635656T2 (de) 5-fluoro-2',3'-ungesättigte pyrimidinnucleoside
DE3854297T2 (de) Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung.
DE3852531T2 (de) Nukleoside und nukleosid-analoge, pharmazeutische zusammensetzung und verfahren für die herstellung der bestandteile.
DE69111232T2 (de) 5-benzyl barbitursäurederivate.
JP2005536440A (ja) ４’位が修飾されたヌクレオシドを使用するフラビウイルスおよびペスチウイルスの治療のための方法および組成物
EP1828145A2 (en) 2' and 3' - substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation
CZ283721B6 (cs) Purinové deriváty a jejich farmaceutické použití
DE4207363A1 (de) Antivirale nucleosidanaloga, ihre herstellung und ihre pharmazeutische verwendung
US5159067A (en) 5'-Diphosphohexose nucleoside pharmaceutical compositions
EP0409227A2 (de) Pyrimidinnucleoside, ihre Herstellung und pharmazeutische Mittel
EP0479336A1 (en) Antiviral compounds
EP1124839B1 (en) Nucleosides with anti-hepatitis b virus activity
DE69823984T2 (de) Synthese, anti-hiv- und anti-hepatitis-b-virus-aktivitäten von 1,3-oxaselenolannukleosiden
DE3873207T2 (de) Antivirale therapie gegen hepatitis b mit 2',3'-didesoxynucleosiden.
DE3689221T2 (de) Hemmung der In-vitro-Infektivität und des zytopathischen Effektes von HTLV-III/LAV durch 2'3'-Dideoxycytidin.
DE69431304T2 (de) Nukleoside und nukleotide mit vergrösserten ringen

Legal Events

Date Code Title Description
8100 Publication of the examined application without publication of unexamined application
D1 Grant (no unexamined application published) patent law 81
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee